Infection Viral Clinical Trial
Official title:
Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
Infection with the SARS-CoV-2 coronavirus strain is associated with severe morbidity and mortality estimated today from 2% to 4%. Elderly patients or patients with serious chronic conditions justifying hospitalization are particularly at risk. The risk of infection with SARS-CoV-2 during hospitalization is also substantial and increased in fragile patients. Several cases of infection among Healthcare Professionals had been reported. The hypothesis is that similar to the corona virus agent responsible for SRAS and the influenza virus, nosocomial outbreaks of SARS-CoV-2 to be feared. Health care professionals and caregivers are populations-at-risk as they are exposed in the community and can transmit SARS-CoV-2 to hospitalized patients, and are also exposed to hospitalized patients infected with SARS-CoV-2. Describing hospital-acquired cases and SARS-CoV-2 infection transmission chains in healthcare settings is vitally essential to achieve control of this epidemic. To improve the quality of care and patient safety, this data must be accompanied by an analysis of the impact of infection control measures. In addition, an effective infection control program is urgently required to control the spread of the virus and protect both uninfected patients who require care for other medical or surgical conditions as well as health care professionals. The main objective of this prospective, non-interventional - observational, hospital based study in adults and children is to describe and document suspected or confirmed cases of nosocomial SARS-CoV-2 infection, the clinical spectrum and the determinants (risk factors/protective factors) at participating hospitals. Characterization of the clinical features of the SARS-CoV-2 infection will help to identify potential sources of virus transmission as rapidly as possible and enable implementation of appropriate hygiene practices in hospitals.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
| Completed |
NCT05041764 -
RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
|
||
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT03818334 -
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
|
Phase 2/Phase 3 | |
| Completed |
NCT04637867 -
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)
|
N/A | |
| Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
| Completed |
NCT05069623 -
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04386460 -
Covid-19 and Prevention of Malnutrition After Confinement by Dentists
|
||
| Completed |
NCT04327180 -
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
|
||
| Recruiting |
NCT04438629 -
Evaluation of Immune Response in COVID-19 Patients
|
||
| Active, not recruiting |
NCT05874713 -
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
|
Phase 2 | |
| Completed |
NCT03163628 -
biomArkers to differeNtiate bacTerial From vIral iNfEctions
|
N/A | |
| Completed |
NCT04924842 -
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
|
||
| Completed |
NCT04354155 -
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
|
Phase 2 | |
| Recruiting |
NCT05875961 -
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
|
Phase 1 | |
| Recruiting |
NCT06379061 -
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
|
||
| Active, not recruiting |
NCT04481529 -
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
|
||
| Recruiting |
NCT05090319 -
Micro-hematology Analyzer for Viral/Bacterial Description
|
||
| Not yet recruiting |
NCT04887233 -
Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
|
N/A | |
| Completed |
NCT04754633 -
Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines
|